*Online event*
Are you currently working in industry in drug discovery? Have you had a least five years’ experience in this sector? Then this leaders panel will offer you a chance to meet other professionals in this area.
Join four market leaders from pharmaceuticals to hear their perspective on the current state of the industry, the challenges it faces and the skills they look for in chemical scientists they employ.
Confirmed speakers:
Alison Jones, Charles River Laboratories, Cambridge
Andy Merritt, LifeArc, Stevenage
AJ Ratcliffe, Domainex, Cambridge
Sarah Skerratt, Charm Therapeutics, London
Jamie Scott, Astra Zeneca, Cambridge
A Q&A will follow with opportunities to ask the market leaders questions in smaller groups. You can send questions ahead of the afternoon or ask directly to speakers in the breakout groups.
Expect to find out:
The panel session is sponsored by SSR (Science Solutions Recruitment) and in consultation with 91AV subject communities.
Are you currently working in industry in drug discovery? Have you had a least five years’ experience in this sector? Then this leaders panel will offer you a chance to meet other professionals in this area.
Join four market leaders from pharmaceuticals to hear their perspective on the current state of the industry, the challenges it faces and the skills they look for in chemical scientists they employ.
Confirmed speakers:
Alison Jones, Charles River Laboratories, Cambridge
Andy Merritt, LifeArc, Stevenage
AJ Ratcliffe, Domainex, Cambridge
Sarah Skerratt, Charm Therapeutics, London
Jamie Scott, Astra Zeneca, Cambridge
A Q&A will follow with opportunities to ask the market leaders questions in smaller groups. You can send questions ahead of the afternoon or ask directly to speakers in the breakout groups.
Expect to find out:
- How important professional membership and external qualifications are when applying for mid-career level roles and which are most attractive
- Which areas of (traditionally non-chemistry) science is essential to progression
- How flexible-working has been implemented since COVID, and how might that continue or change, and what impacts that is having on the traditional company model in drug discovery?
- 2pm: Welcome
- 2.05pm: Presentations from each speaker
- 2.45pm: Q&A
- 3pm: Breakout rooms for delegates to meet each speaker (15 minute rotations)
- Close
The panel session is sponsored by SSR (Science Solutions Recruitment) and in consultation with 91AV subject communities.
